Track Tempest Therapeutics's other current assets ($920K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Tempest Therapeutics (TPST) currently reports a other current assets of $920K as of June 2026. That compares with $820K in the prior-year period — up 11.5% year over year. Use the charts on this page to explore Tempest Therapeutics's other current assets history and peer comparisons.
Tempest Therapeutics's other current assets increased from $820K to $920K — a 11.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Tempest Therapeutics reported $920K in other current assets as of June 2026. That compares with $820K in the prior-year period — up 11.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $920K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tempest Therapeutics, and consider following TPST for alerts when major investors trade the stock.
Tempest Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $920K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TPST with unrelated industries.